Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2025-03-21 Annual Report
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
3.3. UCB SA_Management Report Staturoy Accounts 2024 NL Final.pdf
Annual Report Classification · 1% confidence The document is titled 'Jaarverslag van de Raad van Bestuur' (Annual Report of the Board of Directors) for the fiscal year ending December 31, 2024. It contains detailed financial information, including balance sheet items, profit and loss analysis, dividend proposals, and management commentary on business activities. While it references a separate 'Integrated Annual Report' for consolidated group data, this document itself serves as the statutory annual report for the parent company (UCB NV), fulfilling the criteria for a 10-K equivalent (Annual Report). FY 2024
2025-03-21 Dutch
9.3. Explanatory Note on Remuneration_NL.pdf
Remuneration Information Classification · 1% confidence The document is a detailed explanation and proposal regarding changes to the remuneration policy for UCB's Board of Directors and Executive Committee. It outlines the rationale for these changes, the new global peer group for benchmarking, and specific tables comparing current versus proposed compensation structures. This type of document is typically provided to shareholders as part of the materials for an upcoming general meeting to solicit their approval on executive and director compensation, which falls under the category of Proxy Solicitation & Information Statement.
2025-03-21 Dutch
2.3. Proxy General Meeting 24 April 2025 - NL - Final.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Proxy Solicitation' form (Volmacht voor de Algemene Vergadering) for UCB NV's Annual General Meeting scheduled for April 24, 2025. It provides shareholders with the necessary information and instructions to appoint a proxy and cast votes on specific agenda items, including financial approvals, remuneration, and board appointments. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2025-03-21 Dutch
1.1. EN - Convening notice AGM April 2025 - FINAL 20.03.2025.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Convening Notice to the General Meeting of Shareholders' for UCB SA/NV. It outlines the agenda, proposed resolutions, and participation formalities for an upcoming shareholder meeting. This document is a classic proxy statement/notice of meeting, which falls under the 'Proxy Solicitation & Information Statement' category as it provides shareholders with the necessary information to vote on board appointments, remuneration, and other corporate matters.
2025-03-21 English
1.2 FR - Convening notice AGM April 2025 - FINAL - 20.03.2025.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Convocation à l'assemblée générale des actionnaires' (Notice of Annual General Meeting) for UCB SA. It outlines the agenda, voting proposals, and procedural information for the upcoming meeting on April 24, 2025. This document is a classic proxy statement used to solicit votes and provide shareholders with the necessary information to make decisions on board appointments, remuneration policies, and financial approvals. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2025-03-21 French
1.3 NL - Convening notice AGM April 2025 - FINAL - 20.03.2025.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is an official 'Oproeping tot de Algemene Vergadering' (Notice of Annual General Meeting) for UCB NV. It outlines the agenda items for the meeting scheduled for April 24, 2025, including voting on financial statements, remuneration reports, director appointments, and change-of-control clauses. This document serves as the formal invitation and proxy information package provided to shareholders to solicit their participation and votes, which falls under the Proxy Solicitation & Information Statement category.
2025-03-21 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.